RAB27B

Chr 18

RAB27B, member RAS oncogene family

Also known as: C25KG

RAB27B encodes a small GTPase that regulates intracellular membrane trafficking, vesicle transport, and late endocytic pathway homeostasis, including facilitating axonal transport of neurotrophin receptors. Mutations cause Zimmermann-Laband syndrome, a rare disorder characterized by facial dysmorphism, intellectual disability, and distinctive features including gingival overgrowth and nail dysplasia. The condition follows an autosomal dominant inheritance pattern.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
31
Pubs (1 yr)
59
P/LP submissions
0%
P/LP missense
0.86
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryRAB27B
Population Constraint (gnomAD)
Low constraint (pLI 0.04) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
57 unique Pathogenic / Likely Pathogenic· 27 VUS of 91 total submissions
📖
GeneReview available — RAB27B
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.86LOEUF
pLI 0.039
Z-score 1.89
OE 0.37 (0.180.86)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
0.18Z-score
OE missense 0.95 (0.821.11)
115 obs / 120.4 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.37 (0.180.86)
00.351.4
Missense OE0.95 (0.821.11)
00.61.4
Synonymous OE1.40
01.21.6
LoF obs/exp: 4 / 10.7Missense obs/exp: 115 / 120.4Syn Z: -2.05
DN
0.84top 10%
GOF
0.82top 10%
LOF
0.1993th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

91 submitted variants in ClinVar

Classification Summary

Pathogenic55
Likely Pathogenic2
VUS27
Likely Benign1
55
Pathogenic
2
Likely Pathogenic
27
VUS
1
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
55
0
55
Likely Pathogenic
0
0
2
0
2
VUS
0
23
4
0
27
Likely Benign
0
1
0
0
1
Benign
0
0
0
0
0
Total02461085

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

RAB27B · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →